The Expanding Indication Map for GLP-1 Receptor Agonists

Landmark cardiovascular outcomes trials have reshaped diabetes management by documenting that GLP-1 receptor agonists reduce major adverse cardiovascular events. Tirzepatide produces greater HbA1c lowering and weight reduction, but does that lead to greater CV benefit? The SURPASS-CVOT attempted to answer that question.Guest Authors: Anessa Anand, Pharm.D., Skylar Harrigfeld, Pharm.D., and Christine Schumacher, Pharm.D., FCCP, BCPS, BCACP, BCCP, BC-ADM, CDCESMusic by Good Talk

Could a simple intervention of installing a home appliance lower a patient’s blood pressure and risk of cardiovascular disease (CVD)? The environment we live in, including the air we breathe, has a large impact on our health. What if a high-efficiency particulate air (HEPA) filter could mitigate this risk for patients living in high-risk environments?Guest Authors: Madeline Gutta, PharmD, MBA and Lindsey Westerhof, PharmD, BCACPMusic by: Good Talk

In this special episode of the iForumRx Podcast—produced in collaboration with the ACCP Ambulatory Care Practice and Research Network (AmCare PRN)—Dr. Michelle Balli co-hosts her very first episode as iForumRx's incoming Editor-in-Chief, joined by outgoing Editor-in-Chief Dr. Stuart Haines. Our guests unpack the early warning signs of burnout—from emotional detachment to eroding self-care—and how they differ from everyday fatigue. The panel explores systemic drivers like workload, autonomy, and workplace culture, alongside the real consequences burnout has for patient safety and quality of care. They close with practical strategies for individuals, preceptors, and institutions alike, including recovery habits, gratitude practices, wellness curricula built into experiential rotations, and longitudinal wellbeing programming for residents. A candid, actionable conversation for anyone navigating the demands of pharmacy education and practice.Guests: Hindu Rao, PharmD, BCACP, Neeloufar Fakourfar, PharmD, BCACP, and Seena L. Haines, PharmD, BCACP, NBCHWC

Poor adherence to insulin regimens is a major barrier to achieving good glycemic control. Could once-weekly insulin improve glycemic control, adherence, and patient satisfaction without increasing the risk of hypoglycemia? Authors: Rylee Campbell, PharmD and Kristine M. Cline, PharmD, MSMusic by: Good Talk

DW is a 70-year-old female who has been referred to the clinical pharmacist to optimize her pain management regimen. Chief Complaint: “I don’t think the methadone is working anymore. I spoke with my doctor about switching to a different long-acting pain medication. Can you help me?”Authors: Katherine Matousek, PharmD, Madison G. Pazey, PharmD, and Jubilee Winar, PharmD, BCACPGuest Experts: Stephanie Abel, PharmD, BCPS, and Christopher M. Herndon, PharmD, BCACP, CPEMusic by Good Talk

This podcast was planned in collaboration with the American College of Clinical Pharmacy (ACCP) Ambulatory Care PRN. The glucagon-like peptide-1 (GLP-1) receptors agonists have documented benefits in an expanding array of patient populations are not longer simply "diabetes" and "obesity" medications.Expert Panelists: Lauren Cunningham, PharmD, BCACP, CDCES and Kylee Funk, PharmD, BCPS

Payment for clinical pharmacy services remains a significant challenge, but your odds of success are increased if you know the rules of engagement with various stakeholders. Guests: John Gums, PharmD and Jonathan Hughes, PharmD, BCACPMusic by Good Talk

For patients with overweight or obesity and type 2 diabetes seeking weight reduction and improved glycemic control, the REDEFINE 2 study supports cagrilintide-semaglutide as an effective option. But is it better than other incretin-based therapies already available?Guests: Francesca Reilly, PharmD, Rebecca Munger, PharmD, BCACP, and Jason Zupec, PharmD, BCACPMusic by Good Talk

As methods for estimating kidney function continue to evolve, it's increasingly clear that the venerable Cockroft-Gault equation isn't always the best way to make drug dosing decisions. Here are the top ten things every clinician should know about estimating kidney function.Guests: Michelle Fravel, PharmD, FCCP, BCPS and Isabel Wedig, Pharm.D.Music by Good Talk

In this episode, produced in collaboration with the ACCP Ambulatory Care PRN, host Stuart T. Haines speaks with Drs. Jacqueline Cleary (Albany College of Pharmacy), Crystal Zhou (UCSF), and Briana Murray (Chase Brexton Healthcare), following their 2025 ACCP Annual Meeting session, "Unlocking the Future of Ambulatory Care." The panelists discuss innovative reimbursement strategies—value-based care, shared savings, MTM, and incident-to billing—across a variety of settings. They share practical approaches to advocating for EHR optimization, building patient trust in non-traditional sites such as barbershops, and structuring sustainable collaborative practice agreements that balance patient access with pharmacist workload.